REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Stephan Mayer; Nicolas Bruder; Giuseppe Citero; Andreas Gruber

doi:10.3171/2024.4.JNS232191

REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Stephan Mayer
, Nicolas Bruder
, Giuseppe Citero
, Andreas Gruber

Department of Neurosurgery

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	98-109
Number of pages	12
Journal	Journal of Neurosurgery
Volume	142
Issue number	1
DOIs	https://doi.org/10.3171/2024.4.JNS232191
Publication status	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302051 Neurosurgery

Access to Document

10.3171/2024.4.JNS232191

Cite this

@article{264d927284a6497b8f4eeb1e476566c2,

title = "REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage",

author = "Stephan Mayer and Nicolas Bruder and Giuseppe Citero and Andreas Gruber",

year = "2024",

doi = "10.3171/2024.4.JNS232191",

language = "English",

volume = "142",

pages = "98--109",

journal = "Journal of Neurosurgery",

issn = "0022-3085",

number = "1",

}

REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. / Mayer, Stephan; Bruder, Nicolas; Citero, Giuseppe et al.
In: Journal of Neurosurgery, Vol. 142, No. 1, 2024, p. 98-109.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

AU - Mayer, Stephan

AU - Bruder, Nicolas

AU - Citero, Giuseppe

AU - Gruber, Andreas

PY - 2024

Y1 - 2024

UR - https://www.scopus.com/pages/publications/85205036708

U2 - 10.3171/2024.4.JNS232191

DO - 10.3171/2024.4.JNS232191

M3 - Article

SN - 0022-3085

VL - 142

SP - 98

EP - 109

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

IS - 1

ER -

REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this